Tag: MBC

Prognostic Factors in Metaplastic Carcinoma of the Breast: A Multi-Institutional Study

This 2014 international multicenter study analyzed 405 cases of metaplastic breast carcinoma (MBC) to evaluate clinicopathological features and prognostic factors. The study found that lymph node status, lymphovascular invasion, and histologic subtype significantly influenced outcomes, whereas tumor size and grade did not. Notably, spindle cell carcinoma subtype was associated with

Read More »

Management and Outcomes in Metaplastic Breast Cancer

This 2016 review examines the clinical characteristics, treatment strategies, and outcomes associated with metaplastic breast cancer (MBC), a rare and aggressive subtype of breast cancer. MBC is characterized by its resistance to conventional systemic therapies, including chemotherapy and hormonal therapy, contributing to its poor prognosis. The review discusses the unique

Read More »